Sharon Connaughton

Special Counsel
Full contact info

Experience

Propella Therapeutics Enters Merger Agreement With Astellas Pharma

November 16, 2023

Cooley advised Propella Therapeutics, a privately held biopharmaceutical company that has leveraged a wholly owned proprietary platform that combines medicinal chemistry with lymphatic targeting to create new oncology drugs, on its merger agreement with Astellas Pharma in which Astellas will acquire Propella through a US subsidiary.

Read more

Related contacts

Aaron Binstock
Partner, Washington DC
Kenneth Krisko
Partner, Reston
Lindsey O'Crump
Associate, Washington DC
Danielle Joe
Associate, Washington DC
David Walsh
Partner, Reston
Xander Lee
Partner, Los Angeles Santa Monica
Megan Browdie
Partner, Washington DC
Howard Morse
Partner, Washington DC
Steve Tonsfeldt
Partner, Palo Alto
Christopher Kimball
Partner, Washington DC
Natasha Leskovsek
Of Counsel, Washington DC
Mary Maher Lewis
Special Counsel, Reston
Stacey A. Bradford
Special Counsel, Washington DC
Heather Harrington
Special Counsel, Boston
Stephanie Parker Palmer
Special Counsel, Reston
Stella Sarma
Special Counsel, Brussels
Sharon Connaughton
Special Counsel, Washington DC
Dov Fiskus
Associate, New York
Richard G.S. Lee
Associate, Washington DC
Jennifer Don
Associate, Reston
John Forrest
Associate, Boston
Kevin Milgram
Associate, Reston
Carly Mitchell
Associate, Washington DC
Rick Jantz
Associate, Los Angeles Santa Monica
Virat Gupta
Associate, Washington DC
Amanda Griggs
Associate, New York
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

MapLight Therapeutics Closes Oversubscribed $225 Million Series C

November 3, 2023

Cooley advised MapLight Therapeutics, a clinical-stage biopharmaceutical company, on its oversubscribed $225 million Series C financing.

Read more

Related contacts

Christian Plaza
Partner, Reston
Matthew Schwee
Partner, Reston
David Brinton
Associate, Washington DC
Michael Tuscan
Partner, Washington DC
Jim Fulton
Partner, New York
Natasha Leskovsek
Of Counsel, Washington DC
Sharon Connaughton
Special Counsel, Washington DC
Jason Valentine
Associate, Washington DC
Cortney Smith
Senior Paralegal, Reston
Jeffery Wyzykowski
Patent Agent, Washington DC
Dou Yeon Youn
Patent Agent, New York
Zhipeng Zheng
Patent Agent, Washington DC

Related Practices & Industries

MediLink Therapeutics Announces Strategic Collaboration, Worldwide License Agreement With BioNTech

October 12, 2023

Cooley advised MediLink Therapeutics, a clinical-stage biotech company focused on developing globally competitive conjugated drugs, on its strategic research collaboration and worldwide license agreement with BioNTech.

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Chen Chen
Associate, Palo Alto
Jennifer Raab
Special Counsel, Palo Alto
Natasha Leskovsek
Of Counsel, Washington DC
Amanda Pacheco
Associate, Palo Alto
Sharon Connaughton
Special Counsel, Washington DC
David Burns
Special Counsel, Washington DC

Related Practices & Industries

Immatics Announces Collaboration With Moderna

September 11, 2023

Cooley advised Immatics, a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, on its strategic collaboration with Moderna.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Stephanie Parker Palmer
Special Counsel, Reston
J. Brian Stalter
Special Counsel, New York
Carly Robinson
Associate, Reston
David D. Suh
Associate
Freddy Yip
Associate, Hong Kong
Jacqueline Grise
Partner, Washington DC
Sharon Connaughton
Special Counsel, Washington DC
Rubin Waranch
Associate, Washington DC
Alexander Israel
Partner in Charge – Brussels, Brussels
Stella Sarma
Special Counsel, Brussels
Jan Lang
Associate, Brussels
Kimberly Nguyen
Special Counsel, Reston
Liza Hadley
Associate, Boston
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
Rachel Thorn
Partner, New York
Matthew Pavao
Partner, Boston

Related Practices & Industries

Cellares Announces $255 Million Series C

August 25, 2023

Cooley advised Cellares, the first integrated development and manufacturing organization dedicated to clinical and industrial-scale cell therapy manufacturing, on its $255 million financing.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
William Beom Hong
Associate, Palo Alto
John T. Stellini
Associate, Palo Alto
Kristina Krasnikova
Associate, Palo Alto
Narmada Murugan
Associate, Palo Alto
Sharon Connaughton
Special Counsel, Washington DC
Karen Tsai
Special Counsel, Washington DC
Bryan Berman
Special Counsel, Colorado
Dillon Martinson
Special Counsel, Washington DC
Tania Soris
Associate, New York
John Sellers
Partner, Palo Alto

Related Practices & Industries

View more